| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Michael C Kew | |
| P2860 | cites work | Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma | Q34242558 |
| Mechanisms of aflatoxin carcinogenesis | Q34330987 | ||
| Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein | Q34355312 | ||
| Determinants of formation of aflatoxin-albumin adducts: a seven-township study in Taiwan | Q36624396 | ||
| Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis | Q40386904 | ||
| Hepatitis B virus X protein inhibits nucleotide excision repair | Q40967417 | ||
| Dual effects of hepatitis B virus X protein on the regulation of cell-cycle control depending on the status of cellular p53. | Q42809175 | ||
| Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan | Q43686267 | ||
| Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China | Q45730359 | ||
| Hepatitis B infection and aflatoxin biomarker levels in Gambian children | Q46263138 | ||
| Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa | Q46754150 | ||
| Mutational hot spot in the p53 gene in human hepatocellular carcinomas | Q53499208 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis B virus | Q6844 |
| hepatitis B | Q6853 | ||
| P304 | page(s) | 405-409 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | Liver International | Q15765078 |
| P1476 | title | Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis | |
| P478 | volume | 23 |
| Q97530381 | A bioinformatics investigation into molecular mechanism of Yinzhihuang granules for treating hepatitis B by network pharmacology and molecular docking verification |
| Q92797759 | A global view of hepatocellular carcinoma: trends, risk, prevention and management |
| Q34381551 | Aflatoxin B(1)-Associated DNA Adducts Stall S Phase and Stimulate Rad51 foci in Saccharomyces cerevisiae |
| Q36992263 | Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa |
| Q41306803 | Aflatoxin levels in chronic hepatitis B patients with cirrhosis or hepatocellular carcinoma in Balıkesir, Turkey |
| Q35104623 | Aflatoxins and fumonisins contamination of home-made food (weanimix) from cereal-legume blends for children |
| Q36180341 | Alteration of p53 and p21 during hepatocarcinogenesis in tree shrews |
| Q53687056 | Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000-2012. |
| Q28211269 | Assessing cumulative health risks from exposure to environmental mixtures - three fundamental questions |
| Q99548775 | Biomonitoring of Aflatoxin B1 and Deoxynivalenol in a Rural Pakistan Population Using Ultra-Sensitive LC-MS/MS Method |
| Q24645322 | CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection |
| Q92633778 | Chronic and Acute Toxicities of Aflatoxins: Mechanisms of Action |
| Q36147887 | Comparison of Helicobacter bilis-Associated Protein Expression in Huh7 Cells Harbouring HCV Replicon and in Replicon-Cured Cells |
| Q38950192 | Dietary Exposure and Natural Occurrence of Total Aflatoxins in Basmati Rice of Pakistan |
| Q33788058 | Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States |
| Q47721280 | Early detection of the aflatoxin B1 mutational fingerprint: A diagnostic tool for liver cancer |
| Q53976870 | Effect of dietary acids on the formation of aflatoxin B2a as a means to detoxify aflatoxin B1. |
| Q43245452 | Effect of resveratrol and in combination with 5-FU on murine liver cancer |
| Q34563350 | Epidemiology of primary and secondary liver cancers |
| Q58797385 | Exploration of the Regulatory Mechanism of Secondary Metabolism by Comparative Transcriptomics in |
| Q41931500 | Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure |
| Q35171555 | GST polymorphisms are associated with hepatocellular carcinoma risk in Chinese population |
| Q42220401 | Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification |
| Q57161225 | Global Inequities in Precision Medicine and Molecular Cancer Research |
| Q37177567 | Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma |
| Q34012962 | Hepatitis B virus x gene and cyanobacterial toxins promote aflatoxin B1-induced hepatotumorigenesis in mice |
| Q33787553 | Hepatitis B virus-induced oncogenesis. |
| Q42053469 | Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy |
| Q39631025 | Hepatocellular carcinoma in developing countries: Prevention, diagnosis and treatment |
| Q29615767 | Hepatocellular carcinoma pathogenesis: from genes to environment |
| Q37648701 | Hepatocellular carcinoma: prevalence and molecular pathogenesis of Helicobacter spp. |
| Q37888329 | Hepatocellular carcinoma: the point of view of the hepatitis B virus |
| Q56976434 | Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma |
| Q57495173 | Impact of DNA lesion repair, replication and formation on the mutational spectra of environmental carcinogens: Aflatoxin B as a case study |
| Q24609544 | Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma |
| Q41748054 | Inhibiting Microbial Toxins Using Plant-Derived Compounds and Plant Extracts |
| Q28649881 | Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas |
| Q64236643 | It Takes a Team: A Gain-of-function Story of p53-R249S |
| Q34406436 | Leptin in hepatocellular carcinoma |
| Q34449667 | Mechanisms of alcohol-induced hepatocellular carcinoma |
| Q45410934 | Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase |
| Q35802845 | Molecular characterization of hepatocarcinogenesis using mouse models |
| Q30358204 | Mutational spectra of aflatoxin B1 in vivo establish biomarkers of exposure for human hepatocellular carcinoma. |
| Q93073850 | Non-Cirrhotic Liver is Associated with Poor Prognosis of Hepatocellular Carcinoma: A Literature Review |
| Q46828395 | NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis. I. Study design and clinical outcomes |
| Q34364217 | Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinoma |
| Q34382700 | Polymorphism of glutathione S-transferase mu 1 and theta 1 genes and hepatocellular carcinoma in southern Guangxi, China |
| Q34589307 | Prevention of hepatocellular carcinoma |
| Q28272678 | Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges |
| Q94686324 | Probabilistic risk assessment of dietary exposure to aflatoxin B1 in Guangzhou, China |
| Q28750637 | Rainbow trout (Oncorhynchus mykiss) and ultra-low dose cancer studies |
| Q90383958 | Retrospective and Prospective Look at Aflatoxin Research and Development from a Practical Standpoint |
| Q92669840 | Risk factors for hepatocellular carcinoma |
| Q39877736 | Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression |
| Q35579913 | Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection |
| Q37085701 | Stimulation of sister chromatid exchanges and mutation by aflatoxin B1-DNA adducts in Saccharomyces cerevisiae requires MEC1 (ATR), RAD53, and DUN1 |
| Q47734598 | TP53 codon 72 polymorphism with hepatocellular carcinoma: a metaanalysis |
| Q36777331 | TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer |
| Q92504694 | Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma |
| Q42241369 | The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure |
| Q33405280 | Thrombocytosis and hepatocellular carcinoma |
| Q36418030 | Use of Percutaneous Sonographically Guided Microwave Ablation Therapy to Treat Inoperable Malignant Liver Tumours |
| Q60909319 | Weighing the benefits of hepatocellular carcinoma surveillance against potential harms |
Search more.